You searched for "erectile"

672 results found

What is a leadership fellowship?

What is a leadership fellowship?” This is a question that is often asked about my year out of training to undertake the National Medical Director’s (NMD) Clinical Fellow Scheme. I hope to provide an insight into what a fellowship in...

Laborie: Urodynamic Studies: Basic Interpretation and Approach Webinar

15:00-16:30 CET (Europe) This online webinar explains Urodynamic investigations and curve interpretation in order to improve the performance of examinations in daily practice.

BSUG (British Society of Urogynaecology) Annual Scientific Update in Urogynaecology

This event will combine the latest updates and innovations in current and emerging issues in urogynaecology. This hybrid event is an excellent opportunity for healthcare professionals with an interest in urogynaecology to improve their skills, hear current practice dilemmas and how to manage patients with specific urogynaecological conditions.

Paediatric Nephro-Urology Module 2025

The paediatric nephro-urology course is a primarily virtual module. It consists of four core learning blocks with two additional optional learning blocks. The focus of this course is to deepen the students understanding of the pathology and pathophysiology of childhood nephro- urological conditions. Current treatment modalities and their implications in practice will be explored.

Royal College of Surgeons of Edinburgh: Core Skills in Urology Course Module 1 & 2

This two-day course aimed at CT2 - ST4 level trainees uses lectures, tutorial discussion groups and practical sessions with a variety of 'hands on' models. The course aims to provide junior urology trainees with hands on practical training in basic endoscopic urological surgery offering the opportunity for practice that will augment local training programmes.

BPH therapy: how to find one’s way through the maze?

This communication is from the Young Academic Urologists (YAU) group of the European Association of Urologists (EAU). A purpose-built questionnaire of current practice was sent to 2000 members, of which 637 responded (68% were aged 50 or younger). Alpha blockers...

Tissue-based biomarkers steering clinical decisions in patients with urothelial cancer

Biomarkers play an essential role in the diagnosis and treatment of urothelial cancer (UC), with PD-L1, FGFR, and MMR proteins being the most clinically established. These biomarkers, derived from histological specimens, guide therapeutic decisions for bladder cancer (BCa) and upper...

The Nurse Practitioner in Urology

This book is designed to meet the needs of nurse practitioners, advanced practice nurses and physician assistants working in urology in the US where Advanced Practice Certification, although not mandatory, is highly sought after by employers and service users alike....

Challenging Cases in Urological Surgery: Cases With Expert Commentary (Challenging Concepts)

The authors’ intention with this book is to provide a consensus on a number of common, challenging and controversial topics in urology, which are examined from a multidisciplinary approach with insights from expert opinion and current evidence. Challenging Cases in...

Performance status may alter outcomes in those treated with abiraterone

The drug therapies available for those with metastatic castrate-resistant prostate cancer have increased over the past few years. Abiraterone, a CYP17 inhibitor, has been proven effective in phase three trials, however those with poor performance status were largely under-represented in...

Use of Clavien-Dindo classification in urology part 1 – pelvic surgery

There is no widely accepted system to classify postoperative complications. It is necessary to compare the outcome and complications while validating a new surgical procedure or one of the surgical approaches of a particular condition. Several parameters have long been...

Neuroendocrine bladder tumour

A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...